 | • レポートコード：GIR-107A14957 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、CXCR4拮抗薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。CXCR4拮抗薬の種類別市場規模（BL-8040、GMI-1359、プレリキサフォル（AMD3100）、バリキサフォルチド（POL6326）、USL311、その他）、用途別市場規模（がん、HIV、慢性炎症性疾患）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・CXCR4拮抗薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Sanofi、BioLineRx、X4 Pharmaceuticals、Eli Lilly、Roche、Merck、Biokine Therapeutics、GlycoMimetics、Harmonic Pharma、Upsher-Smith Laboratories ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：BL-8040、GMI-1359、プレリキサフォル（AMD3100）、バリキサフォルチド（POL6326）、USL311、その他 ・用途別分析2016年-2026年：がん、HIV、慢性炎症性疾患 ・CXCR4拮抗薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・CXCR4拮抗薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・CXCR4拮抗薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・CXCR4拮抗薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・CXCR4拮抗薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The CXCR4 Antagonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global CXCR4 Antagonists size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global CXCR4 Antagonists market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
CXCR4 Antagonists market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
BL-8040
GMI-1359
Plerixafor (AMD3100)
Balixafortide (POL6326)
USL311
Others
Market segment by Application, can be divided into
Cancer
HIV
Chronic Inflammatory Diseases
Market segment by players, this report covers
Sanofi
BioLineRx
X4 Pharmaceuticals
Eli Lilly
Roche
Merck
Biokine Therapeutics
GlycoMimetics
Harmonic Pharma
Upsher-Smith Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of CXCR4 Antagonists
1.2 Classification of CXCR4 Antagonists by Type
1.2.1 Overview: Global CXCR4 Antagonists Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global CXCR4 Antagonists Revenue Market Share by Type in 2020
1.2.3 BL-8040
1.2.4 GMI-1359
1.2.5 Plerixafor (AMD3100)
1.2.6 Balixafortide (POL6326)
1.2.7 USL311
1.2.8 Others
1.3 Global CXCR4 Antagonists Market by Application
1.3.1 Overview: Global CXCR4 Antagonists Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Cancer
1.3.3 HIV
1.3.4 Chronic Inflammatory Diseases
1.4 Global CXCR4 Antagonists Market Size & Forecast
1.5 Global CXCR4 Antagonists Market Size and Forecast by Region
1.5.1 Global CXCR4 Antagonists Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global CXCR4 Antagonists Market Size by Region, (2016-2021)
1.5.3 North America CXCR4 Antagonists Market Size and Prospect (2016-2026)
1.5.4 Europe CXCR4 Antagonists Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific CXCR4 Antagonists Market Size and Prospect (2016-2026)
1.5.6 South America CXCR4 Antagonists Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa CXCR4 Antagonists Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 CXCR4 Antagonists Market Drivers
1.6.2 CXCR4 Antagonists Market Restraints
1.6.3 CXCR4 Antagonists Trends Analysis
2 Company Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi CXCR4 Antagonists Product and Solutions
2.1.4 Sanofi CXCR4 Antagonists Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Sanofi Recent Developments and Future Plans
2.2 BioLineRx
2.2.1 BioLineRx Details
2.2.2 BioLineRx Major Business
2.2.3 BioLineRx CXCR4 Antagonists Product and Solutions
2.2.4 BioLineRx CXCR4 Antagonists Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 BioLineRx Recent Developments and Future Plans
2.3 X4 Pharmaceuticals
2.3.1 X4 Pharmaceuticals Details
2.3.2 X4 Pharmaceuticals Major Business
2.3.3 X4 Pharmaceuticals CXCR4 Antagonists Product and Solutions
2.3.4 X4 Pharmaceuticals CXCR4 Antagonists Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 X4 Pharmaceuticals Recent Developments and Future Plans
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business
2.4.3 Eli Lilly CXCR4 Antagonists Product and Solutions
2.4.4 Eli Lilly CXCR4 Antagonists Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Eli Lilly Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche CXCR4 Antagonists Product and Solutions
2.5.4 Roche CXCR4 Antagonists Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Roche Recent Developments and Future Plans
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck CXCR4 Antagonists Product and Solutions
2.6.4 Merck CXCR4 Antagonists Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Merck Recent Developments and Future Plans
2.7 Biokine Therapeutics
2.7.1 Biokine Therapeutics Details
2.7.2 Biokine Therapeutics Major Business
2.7.3 Biokine Therapeutics CXCR4 Antagonists Product and Solutions
2.7.4 Biokine Therapeutics CXCR4 Antagonists Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Biokine Therapeutics Recent Developments and Future Plans
2.8 GlycoMimetics
2.8.1 GlycoMimetics Details
2.8.2 GlycoMimetics Major Business
2.8.3 GlycoMimetics CXCR4 Antagonists Product and Solutions
2.8.4 GlycoMimetics CXCR4 Antagonists Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 GlycoMimetics Recent Developments and Future Plans
2.9 Harmonic Pharma
2.9.1 Harmonic Pharma Details
2.9.2 Harmonic Pharma Major Business
2.9.3 Harmonic Pharma CXCR4 Antagonists Product and Solutions
2.9.4 Harmonic Pharma CXCR4 Antagonists Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Harmonic Pharma Recent Developments and Future Plans
2.10 Upsher-Smith Laboratories
2.10.1 Upsher-Smith Laboratories Details
2.10.2 Upsher-Smith Laboratories Major Business
2.10.3 Upsher-Smith Laboratories CXCR4 Antagonists Product and Solutions
2.10.4 Upsher-Smith Laboratories CXCR4 Antagonists Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Upsher-Smith Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global CXCR4 Antagonists Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 CXCR4 Antagonists Players Market Share
3.2.2 Top 10 CXCR4 Antagonists Players Market Share
3.2.3 Market Competition Trend
3.3 CXCR4 Antagonists Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global CXCR4 Antagonists Revenue and Market Share by Type (2016-2021)
4.2 Global CXCR4 Antagonists Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global CXCR4 Antagonists Revenue Market Share by Application (2016-2021)
5.2 CXCR4 Antagonists Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America CXCR4 Antagonists Revenue by Type (2016-2026)
6.2 North America CXCR4 Antagonists Revenue by Application (2016-2026)
6.3 North America CXCR4 Antagonists Market Size by Country
6.3.1 North America CXCR4 Antagonists Revenue by Country (2016-2026)
6.3.2 United States CXCR4 Antagonists Market Size and Forecast (2016-2026)
6.3.3 Canada CXCR4 Antagonists Market Size and Forecast (2016-2026)
6.3.4 Mexico CXCR4 Antagonists Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe CXCR4 Antagonists Revenue by Type (2016-2026)
7.2 Europe CXCR4 Antagonists Revenue by Application (2016-2026)
7.3 Europe CXCR4 Antagonists Market Size by Country
7.3.1 Europe CXCR4 Antagonists Revenue by Country (2016-2026)
7.3.2 Germany CXCR4 Antagonists Market Size and Forecast (2016-2026)
7.3.3 France CXCR4 Antagonists Market Size and Forecast (2016-2026)
7.3.4 United Kingdom CXCR4 Antagonists Market Size and Forecast (2016-2026)
7.3.5 Russia CXCR4 Antagonists Market Size and Forecast (2016-2026)
7.3.6 Italy CXCR4 Antagonists Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific CXCR4 Antagonists Revenue by Type (2016-2026)
8.2 Asia-Pacific CXCR4 Antagonists Revenue by Application (2016-2026)
8.3 Asia-Pacific CXCR4 Antagonists Market Size by Region
8.3.1 Asia-Pacific CXCR4 Antagonists Revenue by Region (2016-2026)
8.3.2 China CXCR4 Antagonists Market Size and Forecast (2016-2026)
8.3.3 Japan CXCR4 Antagonists Market Size and Forecast (2016-2026)
8.3.4 South Korea CXCR4 Antagonists Market Size and Forecast (2016-2026)
8.3.5 India CXCR4 Antagonists Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia CXCR4 Antagonists Market Size and Forecast (2016-2026)
8.3.7 Australia CXCR4 Antagonists Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America CXCR4 Antagonists Revenue by Type (2016-2026)
9.2 South America CXCR4 Antagonists Revenue by Application (2016-2026)
9.3 South America CXCR4 Antagonists Market Size by Country
9.3.1 South America CXCR4 Antagonists Revenue by Country (2016-2026)
9.3.2 Brazil CXCR4 Antagonists Market Size and Forecast (2016-2026)
9.3.3 Argentina CXCR4 Antagonists Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa CXCR4 Antagonists Revenue by Type (2016-2026)
10.2 Middle East & Africa CXCR4 Antagonists Revenue by Application (2016-2026)
10.3 Middle East & Africa CXCR4 Antagonists Market Size by Country
10.3.1 Middle East & Africa CXCR4 Antagonists Revenue by Country (2016-2026)
10.3.2 Turkey CXCR4 Antagonists Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia CXCR4 Antagonists Market Size and Forecast (2016-2026)
10.3.4 UAE CXCR4 Antagonists Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global CXCR4 Antagonists Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global CXCR4 Antagonists Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market CXCR4 Antagonists Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global CXCR4 Antagonists Revenue (USD Million) by Region (2016-2021)
Table 5. Global CXCR4 Antagonists Revenue Market Share by Region (2021-2026)
Table 6. Sanofi Corporate Information, Head Office, and Major Competitors
Table 7. Sanofi Major Business
Table 8. Sanofi CXCR4 Antagonists Product and Solutions
Table 9. Sanofi CXCR4 Antagonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. BioLineRx Corporate Information, Head Office, and Major Competitors
Table 11. BioLineRx Major Business
Table 12. BioLineRx CXCR4 Antagonists Product and Solutions
Table 13. BioLineRx CXCR4 Antagonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. X4 Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 15. X4 Pharmaceuticals Major Business
Table 16. X4 Pharmaceuticals CXCR4 Antagonists Product and Solutions
Table 17. X4 Pharmaceuticals CXCR4 Antagonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 19. Eli Lilly Major Business
Table 20. Eli Lilly CXCR4 Antagonists Product and Solutions
Table 21. Eli Lilly CXCR4 Antagonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Roche Corporate Information, Head Office, and Major Competitors
Table 23. Roche Major Business
Table 24. Roche CXCR4 Antagonists Product and Solutions
Table 25. Roche CXCR4 Antagonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Merck Corporate Information, Head Office, and Major Competitors
Table 27. Merck Major Business
Table 28. Merck CXCR4 Antagonists Product and Solutions
Table 29. Merck CXCR4 Antagonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Biokine Therapeutics Corporate Information, Head Office, and Major Competitors
Table 31. Biokine Therapeutics Major Business
Table 32. Biokine Therapeutics CXCR4 Antagonists Product and Solutions
Table 33. Biokine Therapeutics CXCR4 Antagonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. GlycoMimetics Corporate Information, Head Office, and Major Competitors
Table 35. GlycoMimetics Major Business
Table 36. GlycoMimetics CXCR4 Antagonists Product and Solutions
Table 37. GlycoMimetics CXCR4 Antagonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Harmonic Pharma Corporate Information, Head Office, and Major Competitors
Table 39. Harmonic Pharma Major Business
Table 40. Harmonic Pharma CXCR4 Antagonists Product and Solutions
Table 41. Harmonic Pharma CXCR4 Antagonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Upsher-Smith Laboratories Corporate Information, Head Office, and Major Competitors
Table 43. Upsher-Smith Laboratories Major Business
Table 44. Upsher-Smith Laboratories CXCR4 Antagonists Product and Solutions
Table 45. Upsher-Smith Laboratories CXCR4 Antagonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global CXCR4 Antagonists Revenue (USD Million) by Players (2019-2021)
Table 47. Global CXCR4 Antagonists Revenue Share by Players (2019-2021)
Table 48. Breakdown of CXCR4 Antagonists by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. CXCR4 Antagonists Players Head Office, Products and Services Provided
Table 50. CXCR4 Antagonists Mergers & Acquisitions in the Past Five Years
Table 51. CXCR4 Antagonists New Entrants and Expansion Plans
Table 52. Global CXCR4 Antagonists Revenue (USD Million) by Type (2016-2021)
Table 53. Global CXCR4 Antagonists Revenue Share by Type (2016-2021)
Table 54. Global CXCR4 Antagonists Revenue Forecast by Type (2021-2026)
Table 55. Global CXCR4 Antagonists Revenue by Application (2016-2021)
Table 56. Global CXCR4 Antagonists Revenue Forecast by Application (2021-2026)
Table 57. North America CXCR4 Antagonists Revenue by Type (2016-2021) & (USD Million)
Table 58. North America CXCR4 Antagonists Revenue by Type (2021-2026) & (USD Million)
Table 59. North America CXCR4 Antagonists Revenue by Application (2016-2021) & (USD Million)
Table 60. North America CXCR4 Antagonists Revenue by Application (2021-2026) & (USD Million)
Table 61. North America CXCR4 Antagonists Revenue by Country (2016-2021) & (USD Million)
Table 62. North America CXCR4 Antagonists Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe CXCR4 Antagonists Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe CXCR4 Antagonists Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe CXCR4 Antagonists Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe CXCR4 Antagonists Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe CXCR4 Antagonists Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe CXCR4 Antagonists Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific CXCR4 Antagonists Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific CXCR4 Antagonists Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific CXCR4 Antagonists Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific CXCR4 Antagonists Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific CXCR4 Antagonists Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific CXCR4 Antagonists Revenue by Region (2021-2026) & (USD Million)
Table 75. South America CXCR4 Antagonists Revenue by Type (2016-2021) & (USD Million)
Table 76. South America CXCR4 Antagonists Revenue by Type (2021-2026) & (USD Million)
Table 77. South America CXCR4 Antagonists Revenue by Application (2016-2021) & (USD Million)
Table 78. South America CXCR4 Antagonists Revenue by Application (2021-2026) & (USD Million)
Table 79. South America CXCR4 Antagonists Revenue by Country (2016-2021) & (USD Million)
Table 80. South America CXCR4 Antagonists Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa CXCR4 Antagonists Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa CXCR4 Antagonists Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa CXCR4 Antagonists Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa CXCR4 Antagonists Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa CXCR4 Antagonists Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa CXCR4 Antagonists Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. CXCR4 Antagonists Picture
Figure 2. Global CXCR4 Antagonists Revenue Market Share by Type in 2020
Figure 3. BL-8040
Figure 4. GMI-1359
Figure 5. Plerixafor (AMD3100)
Figure 6. Balixafortide (POL6326)
Figure 7. USL311
Figure 8. Others
Figure 9. CXCR4 Antagonists Revenue Market Share by Application in 2020
Figure 10. Cancer Picture
Figure 11. HIV Picture
Figure 12. Chronic Inflammatory Diseases Picture
Figure 13. Global CXCR4 Antagonists Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global CXCR4 Antagonists Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global CXCR4 Antagonists Revenue Market Share by Region (2016-2026)
Figure 16. Global CXCR4 Antagonists Revenue Market Share by Region in 2020
Figure 17. North America CXCR4 Antagonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe CXCR4 Antagonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific CXCR4 Antagonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America CXCR4 Antagonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa CXCR4 Antagonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. CXCR4 Antagonists Market Drivers
Figure 23. CXCR4 Antagonists Market Restraints
Figure 24. CXCR4 Antagonists Market Trends
Figure 25. Sanofi Recent Developments and Future Plans
Figure 26. BioLineRx Recent Developments and Future Plans
Figure 27. X4 Pharmaceuticals Recent Developments and Future Plans
Figure 28. Eli Lilly Recent Developments and Future Plans
Figure 29. Roche Recent Developments and Future Plans
Figure 30. Merck Recent Developments and Future Plans
Figure 31. Biokine Therapeutics Recent Developments and Future Plans
Figure 32. GlycoMimetics Recent Developments and Future Plans
Figure 33. Harmonic Pharma Recent Developments and Future Plans
Figure 34. Upsher-Smith Laboratories Recent Developments and Future Plans
Figure 35. Global CXCR4 Antagonists Revenue Share by Players in 2020
Figure 36. CXCR4 Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players CXCR4 Antagonists Revenue Market Share in 2020
Figure 38. Global Top 10 Players CXCR4 Antagonists Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global CXCR4 Antagonists Revenue Share by Type in 2020
Figure 41. Global CXCR4 Antagonists Market Share Forecast by Type (2021-2026)
Figure 42. Global CXCR4 Antagonists Revenue Share by Application in 2020
Figure 43. Global CXCR4 Antagonists Market Share Forecast by Application (2021-2026)
Figure 44. North America CXCR4 Antagonists Sales Market Share by Type (2016-2026)
Figure 45. North America CXCR4 Antagonists Sales Market Share by Application (2016-2026)
Figure 46. North America CXCR4 Antagonists Revenue Market Share by Country (2016-2026)
Figure 47. United States CXCR4 Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada CXCR4 Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico CXCR4 Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe CXCR4 Antagonists Sales Market Share by Type (2016-2026)
Figure 51. Europe CXCR4 Antagonists Sales Market Share by Application (2016-2026)
Figure 52. Europe CXCR4 Antagonists Revenue Market Share by Country (2016-2026)
Figure 53. Germany CXCR4 Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France CXCR4 Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom CXCR4 Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia CXCR4 Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy CXCR4 Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific CXCR4 Antagonists Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific CXCR4 Antagonists Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific CXCR4 Antagonists Revenue Market Share by Region (2016-2026)
Figure 61. China CXCR4 Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan CXCR4 Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea CXCR4 Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India CXCR4 Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia CXCR4 Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia CXCR4 Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America CXCR4 Antagonists Sales Market Share by Type (2016-2026)
Figure 68. South America CXCR4 Antagonists Sales Market Share by Application (2016-2026)
Figure 69. South America CXCR4 Antagonists Revenue Market Share by Country (2016-2026)
Figure 70. Brazil CXCR4 Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina CXCR4 Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa CXCR4 Antagonists Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa CXCR4 Antagonists Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa CXCR4 Antagonists Revenue Market Share by Country (2016-2026)
Figure 75. Turkey CXCR4 Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia CXCR4 Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE CXCR4 Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
CXCR4拮抗薬の世界市場… Scope of the Report: The global CXCR4 Antagonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fa…- 世界のプレリキサフォル市場 2021：企業別、地域別、種類・用途別 The Plerixafor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent …
- 世界のOTC胃腸製品市場予測（～2024年）：メーカー別、地域別、種類・用途別 OTC gastrointestinal agents include many different classes of drugs that are used to treat gastrointestinal disorders. Scope of the Report: The worldwide market for OTC Gastrointestinal Products is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024,…
- 世界のOTC胃腸製品市場予測（～2024年）：メーカー別、地域別、種類・用途別 OTC gastrointestinal agents include many different classes of drugs that are used to treat gastrointestinal disorders. Scope of the Report: The worldwide market for OTC Gastrointestinal Products is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024,…
- 世界のアルツハイマー病治療薬市場予測（～2024年）：メーカー別、地域別、種類・用途別 Alzheimer's is a chronic neurodegenerative disease that usually starts slowly and worsens over time. Scope of the Report: The worldwide market for Alzheimer's Disease Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ i…